Barriera Therapeutics (BTX)

BTX is a preclinical-stage biotech company developing therapies that restore the body’s natural protective barriers. Our lead program targets kidney disease by repairing the glomerular filtration barrier in Alport syndrome. We combine deep biological insight with lean, CRO-driven development to rapi... Read more